| Literature DB >> 32547618 |
Eelyn Chong1, David S Liu2, Neil Strugnell2, Vishnupriya Rajagopal1, Krinal K Mori2.
Abstract
Midgut volvulus in pregnancy is rare but life-threatening, resulting in high maternal and fetal mortality. This surgical emergency commonly masquerades as symptoms of pregnancy, which together with its low incidence often leads to delay in diagnosis and definitive treatment. Here, we review the last three decades of the literature, discuss the challenges in managing this rare condition, and raise awareness among clinicians to minimise loss of life.Entities:
Year: 2020 PMID: 32547618 PMCID: PMC7271231 DOI: 10.1155/2020/2185290
Source DB: PubMed Journal: Obstet Gynecol Int ISSN: 1687-9597
Figure 1Search strategy.
Cases of midgut volvulus in pregnancy (excluding puerperium) from 1990–2019.
| Authors, year | Age (year) | Gestation (weeks) | Symptom duration | Method of diagnosis | Aetiology | Treatment | Maternal outcome (alive/deceased) | Foetal outcome (alive/demised) |
|---|---|---|---|---|---|---|---|---|
| Wax and Christie[ | 31 | 24 | 7 days | AXR | Adhesions from previous surgery | Adhesiolysis, no bowel resection | Alive | Demised |
| Matthews and Soper [ | 18 | 23 | 8 days | Surgery | Congenital gut malrotation | Small and large bowel resection | Alive | Demised |
| Kusnetzoff et al. [ | 30 | 35 | 1 day | AXR | Superior mesenteric thrombosis | Bowel resection and stoma | Deceased | Demised |
| Wheeler et al. [ | 29 | 28 | ND | Surgery | ND | Bowel resection and anastomosis | Alive | Demised |
| Damore et al. [ | 27 | 26 | >7 days | AXR | Congenital gut malrotation | Adhesiolysis, appendectomy | Alive | Alive |
| Ventura-Braswell et al. [ | 22 | 37 | >2 days | Surgery | Congenital gut malrotation | Bowel resection and anastomosis | Alive | Alive |
| Dilbaz et al. [ | 19 | 32 | 1 day | US + surgery | ND | Bowel resection and anastomosis | Alive | Alive |
| Biswas et al. [ | 20 | 31 | >4 days | CT | Adhesions from previous surgery | Bowel resection and anastomosis | Alive | Alive |
| Mahdavi and Yunesi [ | 20 | 10 | >2 days | Surgery | ND | Bowel resection and anastomosis | Alive | Demised |
| Kuwahata et al. [ | 32 | 39 | 4 days | CT | Adhesions from previous surgery | Bowel resection and anastomosis | Alive | Alive |
| Gaikwad et al. [ | 27 | 33 | ND | CT | Superior mesenteric occlusion | Exploratory laparotomy, palliation | Deceased | Demised |
| Shui et al. [ | 25 | 35 | 4 days | Surgery | Superior mesenteric thrombosis | Anticoagulation, no bowel resection | Alive | Alive |
| Siwatch et al. [ | 23 | 20 | >2 days | CT | Congenital gut malrotation | Endoscopic decompression | Alive | Alive |
| Vassiliou et al. [ | 35 | 21 | 2 days | MRI | ND | Bowel resection and anastomosis | Alive | Alive |
| Sharma et al. [ | 28 | 9 | 3 days | Surgery | Congenital gut malrotation | Adhesiolysis, no bowel resection | Alive | Alive |
| Kouki et al. [ | 34 | 14 | ND | MRI | Congenital gut malrotation | ND | ND | ND |
| Nameirakpam et al. [ | 35 | 32 | 2 days | Surgery | ND | Bowel resection and anastomosis | Alive | Demised |
| Hwang et al. [ | 22 | 38 | 9 hours | Surgery | Congenital gut malrotation | Bowel resection | Deceased | Alive |
| Cong et al. [ | 26 | 37 | 8 hours | Surgery | Adhesions from previous surgery | Adhesiolysis, no bowel resection | Alive | Alive |
| Webster et al. [ | 30 | 39 | 1 day | CT | Adhesions from previous surgery | Adhesiolysis, no bowel resection | Alive | Demised |
| Constanthin and Darouichi [ | 29 | 28 | 2 days | MRI | Adhesions from previous surgery | Adhesiolysis, no bowel resection | Alive | Alive |
| Antunes et al. [ | 38 | 27 | ND | MRI | Congenital gut malrotation | Ladd's procedure | Alive | Alive |
| Esterson et al. [ | 28 | 33 | 2 days | CT | Congenital gut malrotation | Adhesiolysis, no bowel resection | Alive | Alive |
AXR: abdominal X-ray; CT: computed tomography; MRI: magnetic resonance imaging; US: ultrasound; ND: not described.
Summary of midgut volvulus by trimester (1990–2019).
| Trimester | Cases (n) | Most used method of diagnosis | Maternal mortality | Fetal mortality |
|---|---|---|---|---|
| 1 (1–12 weeks) | 2 | Surgery ( | 0% | 50% ( |
| 2 (13–28 weeks) | 10 | MRI ( | 0% | 30% ( |
| 3 (29–40 weeks) | 11 | Surgery/CT ( | 25% ( | 36% ( |